Improved diagnosis and prognostication of patients with pleural malignant mesothelioma using biomarkers in pleural effusions and peripheral blood samples - a short report.
Nick BeijeJaco KraanMichael A den BakkerAlexander P W M MaatCor van der LeestRobin CornelissenNgoc M VanJohn W M MartensJoachim G J V AertsStefan SleijferPublished in: Cellular oncology (Dordrecht) (2017)
MCAM-based flow cytometric analysis of pleural effusions is more sensitive than routine cytological analysis. Flow cytometric analysis of pleural effusions and tumor-associated CECs in peripheral blood may serve as a promising approach for the prognostication of MPM patients and, therefore, warrants further study.